Covered recipient · General Payments record
RACHEL ALI SHEETS
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2021–2024
$2,633.75
- Reported across 62 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $467.27 | 12 |
| Education | $42.25 | 5 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $242.16 | 10 |
| Galderma Laboratories, L.P. | $134.88 | 3 |
| REVANCE THERAPEUTICS, INC. | $132.48 | 4 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.87 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106079945 | CMS |
| ABBVIE INC. | $59.99 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106079947 | CMS |
| ABBVIE INC. | $24.64 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106079949 | CMS |
| ABBVIE INC. | $28.41 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106079951 | CMS |
| ABBVIE INC. | $70.00 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106079953 | CMS |
| ABBVIE INC. | $8.45 | 08/26/2024 | Education | Undisputed | 01/23/2026 | 1108185317 | CMS |
| ABBVIE INC. | $8.45 | 08/26/2024 | Education | Undisputed | 01/23/2026 | 1108185319 | CMS |
| ABBVIE INC. | $8.45 | 09/26/2024 | Education | Undisputed | 01/23/2026 | 1106079955 | CMS |
| ABBVIE INC. | $8.45 | 09/26/2024 | Education | Undisputed | 01/23/2026 | 1106079957 | CMS |
| ABBVIE INC. | $8.45 | 09/26/2024 | Education | Undisputed | 01/23/2026 | 1106079959 | CMS |
| Galderma Laboratories, L.P. | $21.92 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145391896 | CMS |
| Galderma Laboratories, L.P. | $98.92 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145391898 | CMS |
| Galderma Laboratories, L.P. | $14.04 | 09/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145391900 | CMS |
| REVANCE THERAPEUTICS, INC. | $35.00 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147950896 | CMS |
| REVANCE THERAPEUTICS, INC. | $28.47 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147950898 | CMS |
| REVANCE THERAPEUTICS, INC. | $36.06 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147950900 | CMS |
| REVANCE THERAPEUTICS, INC. | $32.95 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147950902 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.